165 results on '"Mazzuoli, S."'
Search Results
2. T.04.10: TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB VERSUS VEDOLIZUMAB TREATMENT: A PROSPECTIVE MULTICENTER STUDY
3. Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study
4. A simplified clinical risk score predicts the need for early endoscopy in non-variceal upper gastrointestinal bleeding
5. Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study
6. P621 Efficacy and safety of golimumab in ulcerative colitis. Preliminary data from a multicenter Italian study
7. IBD and Covid-19 in Italy: comparisons between first and second pandemic wave
8. P268 IBD and Covid-19 in italy: comparisons between first and second pandemic wave
9. P613 Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn’s disease patients failure to TNF inhibitors
10. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV 2 infection: an IG-IBD study
11. Two years Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study
12. Total parenteral nutrition-related gastroenterological complications
13. Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism: Multicentre prospective study by the ‘Nutritional Problems in Gastroenterology’ Section of the Italian Society of Gastroenterology (SIGE)
14. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism
15. The practical utility of guidelines in medicine and artificial nutrition
16. Tne assessment of oxidative stress in clinical practice and its importance in nutrition
17. Nutritional strategies in cancer patients. Oral supplementation and artificial nutrition
18. New images of mesenteric artery disease: one of the most common indications for long-term parenteral nutrition
19. TPN-related digestive alterations. Animal and human data in the non-critical setting
20. The PROSit cohort of infliximab biosimilar in IBD: A prolonged follow-up on the effectiveness and safety across Italy
21. EFFICACY OF TEDUGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME ON HOME PARENTERAL NUTRITION: A REAL LIFE STUDY
22. LOW PROTEIN DIET IN THE MANAGEMENT OF CHRONIC KIDNEY DISEASE IMPROVES NUTRITIONAL STATUS AND RENAL FUNCTION
23. OC.09.5 LONG TERM COLECTOMY RATE IN ACUTE SEVERE ULCERATIVE COLITIS. AN ITALIAN MULTICENTER IG-IBD STUDY
24. P.07.14 INTER-OBSERVER AGREEMENT OF ULCERATIVE COLITIS “EXTENDED MAYO ENDOSCOPIC SCORE (EMES)” WITHIN A MULTICENTER INFLAMMATORY BOWEL DISEASE (IBD) TEAM WORK
25. OC.12.1 REAL-LIFE EFFECTIVENESS OF USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH CONCOMITANT PSORIASIS OR PSORIATIC ARTHRITIS: AN IG-IBD STUDY
26. P541 Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: an IG-IBD study
27. P783 Long-term colectomy rate in acute severe ulcerative colitis. An observational multi-centre study on behalf of IG-IBD (Italian group for the study of inflammatory bowel disease)
28. Prospective observational study on inflammatory bowel disease patients treated with infliximab biosimilars: preliminary results of the PROSIT-BIO cohort of the IG-IBD
29. The PROSIT-BIO Cohort of the IG-IBD: A Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab BioSimilars
30. P.07.12 CLINICAL RESPONSE, EFFECTIVENESS, SAFETY AND MUCOSAL HEALING INDUCTION OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A PRELIMINARY REAL-LIFE MULTICENTRIC EXPERIENCE IN SOUTHERN ITALY
31. P.02.10 REAL-LIFE STUDY (GORE-UC) EVALUATING THE EFFECTIVENESS OF GOLIMUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD)
32. Prevalence of home artificial nutrition in Italy in 2005: a survey by the Italian Society for Parenteral and Enteral Nutrition (SINPE)
33. P.11.11: Patients’ Acceptance of Injection Experience with Smartject Autoinjector in Ulcerative Colitis
34. Accelerated Infliximab Infusion: Safety, Factors Predicting Adverse Events, Patients’ Satisfaction and Cost Analysis. A Cohort Study in IBD Patients
35. Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology
36. TPN-related digestive alterations. Animal and human data in the non critical setting
37. TPN related digestive complications in critically ill patients
38. Penetration of solar radiation into waters of Messina Strait (Italy)
39. Spatial and temporal characterisations of dissolved humic substances in freshwater lake
40. The spatial distribution of the optical properties in the UV and Visible in an aquatic ecosystem
41. A simplified clinical risk score predicts the need for early endoscopy in non-variceal upper gastrointestinal bleeding
42. OC.14.1 OBESITY, MALNUTRITION AND NUTRITIONAL RISK IN ITALIAN GASTROENTEROLOGY UNITS: A MULTICENTER STUDY
43. P.01.22 MUCOSAL HEALING AND HISTOLOGICAL IMPROVEMENT AFTER ONE YEAR INFLIXIMAB THERAPY: A CLINICAL CASE OF ENTERO BEHCET'S DISEASE
44. P.06.10 HEPATOBILIARY COMPLICATIONS OF LONG-TERM HOME PARENTERAL NUTRITION IN ADULT NON-CANCER PATIENTS WITH CHRONIC INTESTINAL FAILURE: A SINGLE HPN NUTRITION TEAM'S 25-YEAR EXPERIENCE
45. P.01.20 SAFETY OF LONG-TERM INFLIXIMAB AND ADALIMUMAB TREATMENTS IN CROHN'S DISEASE
46. Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE)
47. P.16.5 HOME PARENTERAL NUTRITION IS AN ALTERNATIVE THERAPEUTIC OPTION FOR ABDOMINAL ABSCESSES IN CROHN'S DISEASE
48. P.05.6 ENDOSCOPIC SCORING SYSTEMS FOR THE EVALUATION OF MUCOSAL HEALING IN ANTI TNF-ALPHA TREATED CROHN'S DISEASE PATIENTS
49. P.06.12 NUTRITIONAL EFFECTS OF ANTI-TNF-ALPHA THERAPY IN MODERATE-SEVERE CROHN'S DISEASE PATIENTS
50. P.1.237: BIOLOGIC TREATMENT IN IBD PATIENTS: EFFECTS OF LENGTH OF THERAPY IN INDUCING MUCOSA HEALING
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.